Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse effects associated with the newer inotropic agents.

M W Webster, D N Sharpe

    Medical Toxicology
    |September 1, 1986
    PubMed
    Summary

    Developing ideal inotropic agents for long-term heart failure treatment remains challenging. Current options, including beta-agonists and non-catecholamines, show limited long-term oral efficacy due to adverse effects and tolerance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Late drug-eluting stent thrombosis and erythropoietin: cause and effect?

    Heart, lung & circulation·2007
    Same author

    Mechanical properties and microstructure of intraluminal thrombus from abdominal aortic aneurysm.

    Journal of biomechanical engineering·2002
    Same author

    Presidential address: A belated obituary.

    Journal of vascular surgery·2001
    Same author

    Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention.

    Circulation·2001
    Same author

    Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening.

    Journal of vascular surgery·2001
    Same author

    Outcome events in patients with claudication: a 15-year study in 2777 patients.

    Journal of vascular surgery·2001

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • The search for ideal inotropic agents continues, aiming for oral and parenteral availability, long-term efficacy, and minimal adverse effects.
    • Digoxin alternatives are actively being developed to improve cardiac contractility management.

    Purpose of the Study:

    • To review the development and clinical evaluation of novel inotropic agents.
    • To assess the long-term safety and efficacy of new inotropic drug candidates.

    Main Methods:

    • Review of recent pharmacological research and clinical trials.
    • Analysis of adverse effect profiles and development of tolerance for various inotropic agents.

    Main Results:

    • Beta-agonists demonstrate short-term parenteral utility but face limitations in long-term oral use due to adverse effects and tolerance.
    • Non-catecholamine agents with inotropic and vasodilator properties have shown frequent and occasionally severe adverse effects.
    • No new inotropic agent has yet demonstrated proven long-term safety and efficacy in clinical trials.

    Conclusions:

    • Current novel inotropic agents have not yet met the criteria for ideal long-term therapy.
    • Further research is needed to identify safer and more effective long-term inotropic treatments for conditions like heart failure.

    Related Experiment Videos